Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

New compounds were made that are promising for prostate cancer therapy.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Mesenchymal stromal cell therapies show promise for treating various diseases but need more research and standardization.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

The Wnt/β-catenin pathway is important for tissue development and has potential in regenerative medicine, but requires more research for therapeutic use.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Different cell types work together to repair skin, and targeting them may improve healing and reduce scarring.

ALRN-6924 may prevent hair loss caused by chemotherapy.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

Apoptosis is crucial for healthy skin and treating skin diseases.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

The silk fibroin-based hydrogel shows promise for treating melanoma and healing infected wounds by killing tumor cells and bacteria, and supporting skin recovery.

Changing the environment around stem cells could help tissue repair, but it's hard to be precise and avoid side effects.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Targeted cancer therapies often cause serious skin problems that need careful management.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

Huaier helps hair grow back and repairs tissue after cancer treatment.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Tempol is safe and may prevent hair loss from brain radiotherapy.

Some cancer treatments can cause abnormal fine hair growth.

Low zinc levels may be linked to the return of gynecologic cancers.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

The new drug carriers show promise for better targeting and treating ovarian cancer.